Department of Biology, Faculty of Science, Yazd University, Yazd, Iran.
Department of Cardiovascular Surgery, Afshar Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Appl Biochem Biotechnol. 2020 Jul;191(3):1326-1339. doi: 10.1007/s12010-020-03275-0. Epub 2020 Feb 25.
A wide range of genetic and environmental interactions are involved in the development of coronary artery disease (CAD). Considerable evidence suggests that mitochondrial DNA mutations are associated with heart failure. In this work, we examined the possible mutations in hotspot mitochondrial genes and their association with Iranian patients with coronary artery disease. In this case-control study, nucleotide variations were investigated in 109 patients with coronary atherosclerosis and 105 control subjects with no family history of cardiovascular disease. The molecular analysis of related mitochondrial genes was performed by polymerase chain reaction sequencing. Our results showed 25 nucleotide variations (10 missense mutations, 9 synonymous polymorphisms, and 6 variants in tRNA genes) that for the first time were presented in coronary artery disease. Our results suggest that novel heteroplasmic m.8231 C>A mutation is involved in CAD (p = 0.007). These nucleotide variations suggest the role of mitochondrial mutations as a predisposing factor which in combination with environmental risk factors may affect the pathogenesis of coronary atherosclerosis. So, further investigation is needed for a better understanding of the pathogenesis and predisposing effects of these variations on the disease.
多种遗传和环境相互作用与冠状动脉疾病 (CAD) 的发生有关。大量证据表明,线粒体 DNA 突变与心力衰竭有关。在这项工作中,我们研究了热点线粒体基因的可能突变及其与伊朗 CAD 患者的关联。在这项病例对照研究中,对 109 名冠状动脉粥样硬化患者和 105 名无心血管疾病家族史的对照组进行了核苷酸变异分析。通过聚合酶链反应测序对相关线粒体基因的分子分析。我们的结果显示了 25 个核苷酸变异(10 个错义突变、9 个同义多态性和 6 个 tRNA 基因变异),这些变异首次在冠状动脉疾病中出现。我们的结果表明,新型异质型 m.8231 C>A 突变与 CAD 有关(p=0.007)。这些核苷酸变异提示线粒体突变作为易感因素的作用,与环境危险因素相结合可能影响冠状动脉粥样硬化的发病机制。因此,需要进一步研究以更好地了解这些变异对疾病的发病机制和易感性的影响。